source
- Patient dies after receiving Bristol Myers experimental autoimmune CAR-T therapy zola-celA participant in Bristol Myers Squibb’s multiple sclerosis trial died 44 days after being infused with the experimental cell therapy known as zola-cel. The company disclosed that the patient develo…
- Bristol Myers Squibb partners with Institute for Healthcare Improvement to increase cancer trial participationBristol Myers Squibb has entered a three-year collaboration with the Institute for Healthcare Improvement called the Cancer Collective Action Collaborative. The program will bring together 24 team…